Gene Query: TM2D3

Dataset Description Geneva Score
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 32.67
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 31.37
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 31.37
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 28.1
Triple vectors expand AAV transfer capacity in the retina 27.87
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 22.46
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 21.28
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 18.34
Cleavage Factor Im as a key regulator of 3’ UTR length 16.66
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 16.28
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 11.01
Differential gene expression of human melanoma cells [RNA-seq] 11.01
Biological effect of chronic mistranslation in mammalian cells 10.27
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.79
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 9.48
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 9.48
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.47
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.5
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.5
Transcriptome of diurnal human blood neutrophils 8.16
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 8.14
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.1
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 8.0
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.85
scRNASeq analysis of cycling cardiomyocytes 7.4
MeRIP-seq for heat shock in B-cell lymphoma cells 7.2
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.8
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.79
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.57
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 6.46
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 6.39
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.29
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.27
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.27
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.23
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 6.22
DART-seq: an antibody-free method for global m6A detection 6.13
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.98
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 5.88
RNA-seq of tumor cells following angiopellosis extravasation 5.87
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.82
The comparison of high-throughput single-cell RNA-seq methods 5.63
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 5.63
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.61
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 5.57
4sU-seq of HFF exposed to salt and heat stress 5.57
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 5.54
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.47
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 5.41
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.37
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.27
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.24
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.21
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.13
RNAseq of HEK293 cells after Chtop knockdown 5.13
Co-transcriptional loading of RNA export factors shapes the human transcriptome 5.13
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.13
3’ Uridylation Expands miRNA Target Repertoire 5.06
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.05
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.04
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.01
RNA-sequencing of human liver tissue 4.97
CROP-Seq in Primary Human T Cells 4.96
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.94
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.89
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.77
Transcriptome analysis of CNS leukemia 4.77
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.77
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.68
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.6
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.6
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 4.57
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.56
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.56
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.5
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.5
mRNA expression profile of Lymphocytes 4.4
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 4.39
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 4.3
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.3
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.3
Transcriptome of activated human and mouse MAIT cells 4.29
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.27
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.2
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.12
Determining mRNA half-lives on a transcriptome-wide scale 4.11
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.1
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.08
Transcriptional profile in human S. haematobium infection 4.08
Trans-differentiation of human adult peripheral blood T cells into neurons 4.06
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 4.05
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 4.05
SLAM-seq for K562 endogenous mRNA decay 4.05
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.05
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.04
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.04
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.04
Identification of renal resident macrophages across species 4.03
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.99
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.99
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.95
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.92
Gene expression in GBM with Cav3.2 inhibition 3.86
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.83
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.81
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.78
Transcriptome analysis of H9 hESC derived cerebral organoids 3.77
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.75
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 3.74
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.74
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.72
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 3.7
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.66
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.66
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 3.63
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.62
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.62
RNA-seq of YB5 cells treated with Proscillaridin A 3.61
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.61
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.58
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.56
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.55
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.53
Effect of PRDM11 depletion in U2932 cells 3.51
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.51
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.49
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 3.49
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 3.49
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 3.48
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.46
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.46
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 3.46
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.44
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 3.41
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.4
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.39
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.36
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 3.36
Examining serotonergic neuron differentiation from human iPSCs 3.35
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.34
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.31
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 3.31
Hepatocyte maturation 3.29
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.29
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.27
Expression profiling of etoposide-induced senescent cells 3.25
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.24
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.22
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.2
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.19
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.19
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.18
Single-cell analysis of human kidney organoids 3.15
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.13
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 3.11
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 3.09
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.06
Landscape of H3K4me3 in human CD19 cells 3.05
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 3.05
The regulartory role of ZCCHC24 in splicing machinery 3.05
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.05
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.03
Short and Long RNA sequencing of human mature erythrocytes 2.99
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.99
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.99
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 2.98
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.97
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.97
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 2.97
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.96
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.96
Transcriptional profiling of microglia; current state of the art and future perspectives 2.94
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.93
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.93
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.92
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 2.91
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.89
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.89
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.88
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.88
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.88
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 2.88
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 2.88
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.87
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.86
Profiling of escape kinetics of viruses subjected to RNAi 2.86
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.86
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.81
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.81
TT-Seq captures the human transient transcriptome 2.8
RNAseq Study in CC-671 Treated Cal-51 Cells 2.8
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.79
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.78
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 2.78
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.78
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 2.76
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.75
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.74
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.71
Global analysis of enhancer targets: Mosaic-seq 2.7
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.7
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.67
CircRNAome diversity in human mature B-cells, T-cells and monocytes 2.67
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.66
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.63
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.63
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 2.63
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.62
Human cell line and subcutaneous tumor 2.59
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.58
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.58
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.57
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.57
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.56
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.56
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.53
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 2.52
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.52
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.52
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.51
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.51
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.51
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.48
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.47
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.47
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.46
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.45
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.41
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.4
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.4
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 2.37
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.36
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.36
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.35
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.34
Identification of renal resident macrophages across species [C1] 2.32
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.28
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.28
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.28
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 2.26
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.26
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.25
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.24
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.23
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.23
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.23
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.22
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.2
Transciptomic profiling of human fetal lung samples 2.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.16
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.16
Effect of drugs on transcriptomic profiles 2.15
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.14
Tracking distinct RNA populations using efficient and reversible covalent chemistry 2.1
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.1
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.1
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 2.1
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.08
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.05
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 2.03
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.02
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.02
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 2.01
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.99
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.95
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.95
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.94
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.92
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.91
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.91
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.9
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 1.89
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 1.87
Mapping interactions for the TNIP2 hub protein 1.86
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 1.85
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.81
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.79
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.78
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.78
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.76
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.69
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.66
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.66
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.65
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.64
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.64
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.63
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.63
quanTIseq: quantifying immune contexture of human tumors 1.63
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.6
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.6
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 1.6
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.59
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 1.58
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.57
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.56
NHLRC1 re-expression in cancer cells 1.52
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.51
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 1.51
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.5
HEK293 TFAM Knockout Expression Study 1.5
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.5
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.5
Tpl-2 small molecule project 1.49
Tpl-2 and MEK small molecule inhibitors 1.49
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.48
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.48
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.48
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.48
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.48
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.45
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.45
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.45
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.45
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.43
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.43
RNAseq in Alzheimer's Disease patients 1.43
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.42
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.41
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.39
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.37
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.37
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.36
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.35
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.34
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.33
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.31
The pause-initiation limit restricts transcription activation in human cells 1.29
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.29
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.28
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.28
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.24
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.23
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.23
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.22
Gene expression signatures of innate lymphoid cells from human blood 1.2
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.2
The cytokine environment influence on human skin-derived T cells 1.19
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.19
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.17
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.17
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.15
Gene expression analysis upon mtDNA depletion 1.15
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.13
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.11
Transcriptomic analysis of human tonsillar TFH subsets 1.05
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.05
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.05
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.05
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.04
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.03
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.03
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.01
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.01
RNA-Seq from human ILC transitional populations 1.0
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.0
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.99
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.99
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.97
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.97
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.97
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.96
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.96
Transcriptome analysis upon C6orf203 silencing 0.96
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.92
Controlling for gene expression changes in transcription factor protein networks. 0.92
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.88
The role of CFTR in islet function 0.88
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.87
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.87
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.84
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.83
MicroRNA-125a-5p overexpression in human macrophages 0.82
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.82
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.82
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.82
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.8
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.8
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.78
Systematic discovery of endogenous human ribonucleoprotein complexes 0.77
siRNA-mediated knockdown 0.76
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.76
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.74
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.73
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.72
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.7
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 0.69
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.68
Activity-dependent transcriptional changes in human neurons 0.67
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.66
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.65
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.65
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.64
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.64
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.63
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.62
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.62
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.62
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.61
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.61
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.58
Dermal endothelial cells of type 2 diabetic patients 0.58
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.56
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.55
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.55
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.55
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.54
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.54
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.53
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 0.52
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.51
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.51
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.51
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.51
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.47
A single-cell transcriptome atlas of the human pancreas 0.47
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.47
Downregulation of LATS kinases alters p53 to promote cell migration 0.46
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.46
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.46
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.45
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.45
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.43
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.42
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.4
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.39
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.39
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.38
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.37
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.37
Epigenomic conservation of transposable element silencing [RNA-seq] 0.37
Epigenomic conservation of transposable element silencing 0.37
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.37
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.37
iPSC derived motor neuron cultures from C9ORF72 carriers 0.37
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.35
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.34
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.34
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.33
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.33
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.32
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.31
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.31
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.31
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.3
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.29
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.28
mRNA recovered upon RNF219 IP. [RNA-IP] 0.26
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.25
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.25
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.25
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.24
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.23
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.22
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.22
Interphase condensins regulate ligand-depedent enhancer activation 0.2
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.2
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.18
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.18
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.17
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.17
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.17
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.17
Aging-associated patterns in the expression of human endogenous retroviruses 0.16
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.15
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.15
Human Treg IL-12 stimulation 0.14
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.13
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.13
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.11
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.1
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.1
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.1
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.09
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.09
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.09
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.08
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.08
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.07
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.06
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.06
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.04
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.04
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.04
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Human Tfh cell RNA bulk sequencing 0.03
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.03
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.02
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.02
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation